From: Effects of dietary components on high-density lipoprotein measures in a cohort of 1,566 participants
Baseline characteristics | CLEAR cohort (N = 1566) |
---|---|
Ethnicity, n (%) | Â |
  European ancestry, not Hispanic | 1207 (77.1) |
  Hispanic ancestry | 33 (2.1) |
  African ancestry | 128 (8.2) |
  Asian/Pacific Islander ancestry | 198 (12.6) |
Gender, n (%) | Â |
  Female | 575 (36.7) |
  Male | 991 (63.3) |
Age, mean ± SD, years | 65.3 ± 9.55 |
Current smoker, n (%) | 161 (10.3) |
Diabetic, n (%) | 275 (17.6) |
Statin Use, n (%) | 515 (32.9) |
Alcohol Intake | Â |
  0 = 0 g/day, n (%) | 641 (40.9) |
  1 = 0 – 12 g/day, n (%) | 588 (37.5) |
  2 = 12 – 24 g/day, n (%) | 178 (11.4) |
  3 = 24 – 60 g/day, n (%) | 126 (8.1) |
  4 = >60 g/day, n (%) | 33 (2.1) |
Dietary Micronutrient Intake | Â |
  Ln(Vitamin C intake), mg, mean ± SD | 5.43 ± 1.00 |
  Ln(Folate intake), μg, mean ± SD | 6.71 ± 0.71 |
  Ln(Iron intake), mg, mean ± SD | 14.6 ± 6.53 |
  Ln(Magnesium intake), mg, mean ± SD | 5.79 ± 0.44 |
  Ln(Carbohydrate intake), g, mean ± SD | 5.26 ± 0.46 |
  Ln(Protein intake), g, mean ± SD | 4.36 ± 0.41 |
  Ln(Dietary fiber intake), g, mean ± SD | 2.92 ± 0.49 |
  Ln(Myristic acid (14:0) intake), g, mean ± SD | 1.01 ± 0.36 |
  Ln(Arachidonic acid (20:4) intake), g, mean ± SD | 0.14 ± 0.075 |
  Ln(Eicosapentaenoic acid (20:5) intake), g, mean ± SD | 0.14 ± 0.13 |
Fat Intake Composition | Â |
  Animal-based fat (of total fat intake), mean ± SD, % | 37.4 ± 21.1 |
  Vegetable-based fat (of total fat intake), mean ± SD, % | 32.5 ± 18.8 |
Plasma Lipid Measures | Â |
  ApoA1, mean ± SD, mg/dl | 150.5 ± 28.8 |
  HDL-C, mean ± SD, mg/dl | 54.4 ± 17.2 |
  HDL-2, mean ± SD, mg/dl | 11.1 ± 6.75 |
  HDL-3, mean ± SD, mg/dl | 43.3 ± 11.6 |